“Medtronic plc (NYSE: MDT) announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the ZEVO(TM) Anterior Cervical Plate System. This system is now commercially available for the treatment of cervical degenerative disc disease, trauma, tumors, deformity
“Medtronic plc (NYSE: MDT) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for expanded indications of specific StealthStation® electromagnetic (EM) surgical navigation system instruments for pediatric and adult cranial and ENT procedures. The clear
“Medtronic plc (NYSE: MDT), today announced the launch of the DIVERGENCE(TM) Stand Alone Interbody Cage. This device is now commercially available for the treatment of anterior cervical interbody fusion procedures in skeletally mature patients with cervical disc disease at one level from the C2-C3
“Medtronic plc (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and U.S. launch of the Euphora(TM) Semicompliant Balloon Dilatation Catheter, a pre-dilatation therapy used during a stent implantation to reopen a narrowed coronary artery caused by plaque buil
“Medtronic plc (NYSE: MDT) today announced its schedule of notable clinical studies that will be presented at Heart Rhythm 2015, the Heart Rhythm Society's 36th Annual Scientific Sessions in Boston, including two late-breaking clinical trials featuring the Evera MRI® SureScan® implantable cardio
“Medtronic plc (NYSE: MDT) today announced the first in-office implant of its miniaturized cardiac monitor as part of the Medtronic Reveal LINQ In-Office 2 (RIO 2) Study. The world's smallest cardiac monitor was successfully implanted in an office setting at Scripps Clinic in La Jolla, California,
“Based on the market-leading Endurant platform, the Endurant Evo AAA stent graft system features an evolved design that aims to simplify the implant procedure and increase patient customization options. The study's two principal investigators -- Prof. Gilbert R. Upchurch, Jr., MD, chief of vascula
“ that it has reached agreement on the terms of a consent decree with the U.S. Food and Drug Administration (FDA) specific to the company's SynchroMed® drug infusion system and the Neuromodulation quality system. The agreement is subject to approval by the U.S. District Court for the District of
“ For endovascular repair of abdominal aortic aneurysms, the Endurant(TM) AAA stent graft system from Medtronic plc (NYSE: MDT) delivered consistently strong results in patients with short and standard neck lengths who were enrolled in the global ENGAGE registry -- the largest contemporary databas
“Medtronic plc (NYSE: MDT) today announced the start of a clinical study using Medtronic technologies to determine whether paroxysmal and persistent atrial fibrillation (AF) can be treated with a combination of two ablation procedures targeting different anatomical locations - specifically, the pu
“ announced that systems within its Activa® portfolio of Deep Brain Stimulation (DBS) Therapy neurostimulators have received European regulatory approval for MR Conditional full-body Magnetic Resonance Imaging (MRI).[*] The expanded approval for full-body MRI scans applies to all patients receivi
“Medtronic plc (NYSE: MDT) today announced the start of a new feasibility study to evaluate the safety and effectiveness of the Valiant Mona LSA branch thoracic stent graft system, an investigational medical device designed to enable a completely endovascular solution for aortic aneurysms encroach
“SWIFT PRIME and REVASCAT Confirm Findings of EXTEND-IA, ESCAPE and MR CLEAN, Support Addition of Solitaire Stent Thrombectomy to Current Standard of Care DUBLIN - April 17, 2015 - Two global trials published online in The New England Journal of Medicine (NEJM) and presented at the European Stroke
“that they will work together to combine powerful analytics and cognitive computing with diabetes medical devices and health data to develop a new generation of personalized diabetes management solutions. People using Medtronic diabetes solutions could benefit from new solutions developed in colla
“Medtronic plc (NYSE: MDT)today announced it has received CE (Conformité Européenne) Mark of the Micra® Transcatheter Pacing System (TPS), the world's smallest pacemaker. At less than one-tenth the size of traditional pacemakers, the Micra device provides the most advanced pacing technology ava
“The global leader in medical technology for endovascular aortic repair (EVAR), Medtronic plc (NYSE: MDT) today announced that it plans to develop a stent graft system for less invasive treatment of thoracoabdominal aortic aneurysms under an exclusive patent license agreement with South Dakota-bas
“ Medtronic plc (NYSE: MDT) today announced the first patient enrollment in the GOLD AF Registry, a first-of-its-kind, prospective, observational clinical study of its Phased Radiofrequency (RF) Ablation technology for treating patients with symptomatic atrial fibrillation (AF). The multicenter re
“Medtronic plc (NYSE: MDT) enhances its leading directional atherectomy portfolio with the U.S. launch of the HawkOne(TM) directional atherectomy system. The HawkOne system provides physicians with a solution to treat all plaque morphologies in patients with peripheral arterial disease, including
Press Release | Newsroom | Medtronic
Press Release | Newsroom | Medtronic
Press Release | Newsroom | Medtronic
Press Release | Newsroom | Medtronic
Press Release | Newsroom | Medtronic
Press Release | Newsroom | Medtronic
Press Release | Newsroom | Medtronic
Press Release | Newsroom | Medtronic
Press Release | Newsroom | Medtronic
Press Release | Newsroom | Medtronic
Press Release | Newsroom | Medtronic
Press Release | Newsroom | Medtronic
Press Release | Newsroom | Medtronic
Press Release | Newsroom | Medtronic
Press Release | Newsroom | Medtronic
Press Release | Newsroom | Medtronic
Press Release | Newsroom | Medtronic
Press Release | Newsroom | Medtronic
Press Release | Newsroom | Medtronic
Press Release | Newsroom | Medtronic